Barriers to care for breast cancer: A qualitative study in Ireland

European Journal of Cancer Care
Julianne ByrneBryan Hennessy

Abstract

Disparities in survival after breast cancer persist. Cancer registry data that are often used to assess associated factors only explain some of the differences. The purpose of this study was to obtain information from disadvantaged Irish women concerning possible barriers to care for breast cancer above and beyond risk factors collected by cancer registries. We used a qualitative interview study with disadvantaged women in treatment for breast cancer, following the methods of thematic analysis. Important themes potentially related to disparity occurred in each treatment phase. Before diagnosis themes included delays in diagnosis. During treatment themes concerned surgical complications, communication difficulties and use of alternative therapies. During the post treatment phase a strong theme was lack of compliance with hormone therapy. Overarching themes were stress related to disadvantage, including financial difficulties, obesity, alcohol use, fears of eviction from home, worry about dependent relatives. Future studies of the breast cancer survival gap arising from socio-economic disadvantage may benefit from a mixed-methods approach that combines cancer registry data with personal interviews to understand the persistence of...Continue Reading

References

Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeJerry Avorn
Feb 22, 2003·Journal of the American College of Surgeons·Soji F OluwoleHarold P Freeman
Oct 28, 2008·Cancer·Karen M FreundUNKNOWN Patient Navigation Research Program Group
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanAlfred I Neugut
Jul 2, 2011·Journal of the National Cancer Institute·Jennifer L PatnaikDana Dabelea
Sep 14, 2013·European Journal of Public Health·Jacek JassemPiotr Zaborek
Nov 15, 2013·Clinical Epidemiology·Mette SøgaardMette Nørgaard
Dec 10, 2013·The Lancet Oncology·Roberta De AngelisUNKNOWN EUROCARE-5 Working Group
Jan 21, 2014·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Mira L KatzElectra D Paskett
Dec 30, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pamela J Goodwin
Jan 27, 2016·Journal of Adolescent and Young Adult Oncology·Hayley E WalkerAnn H Partridge
Feb 10, 2016·Frontiers in Oncology·Jessica L Krok-SchoenElectra D Paskett
Jul 3, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Shirley M BluethmannJulia H Rowland
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles GuenanciaCatherine Vergely
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heather GreenleeWei Yann Tsai
Dec 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michelle C JanelsinsGary R Morrow
Jan 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nis P SuppliSusanne O Dalton
Aug 23, 2017·Indian Journal of Palliative Care·Ram R AmritanshuB S Ajaikumar
Sep 20, 2017·Journal of the National Cancer Institute·Skyler B JohnsonJames B Yu

❮ Previous
Next ❯

Citations

Mar 17, 2021·Journal of Cancer Survivorship : Research and Practice·Margaret I FitchChristopher J Longo
Jul 3, 2021·Patient Education and Counseling·Courtney C RogersRupa S Valdez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.